首页> 外文学位 >Mechanisms of ascorbic acid antioxidant activity in vitro and in vivo.
【24h】

Mechanisms of ascorbic acid antioxidant activity in vitro and in vivo.

机译:体内和体外抗坏血酸抗氧化活性的机制。

获取原文
获取原文并翻译 | 示例

摘要

Reactive oxygen species can mediate the oxidation of low density lipoprotein (LDL): a critical step in the pathogenesis of atherosclerosis. Conversely, antioxidants can protect against such oxidative damage by directly scavenging radical species. Ascorbic acid is a water-soluble antioxidant and strong reducing agent that directly quenches reactive oxygen species and can inhibit oxidative modification of LDL.;To investigate the role of ascorbic acid in LDL oxidation and the pathogenesis of atherosclerosis, I isolated human LDL and showed that ascorbic acid prevented copper mediated oxidation of LDL. The incubation of ascorbic acid and copper with LDL resulted in 2-oxohistidine formation concomitant with the loss of copper binding to LDL. These results suggest a mechanism by which ascorbic acid covalently modifies LDL at transition metal binding sites on apo B, thereby inhibiting LDL oxidation.;To further investigate the role of histidine residues in copper induced LDL oxidation, I incubated LDL with diethylpyrocarbonate, a histidine specific modifying reagent. This modification of LDL inhibited subsequent oxidation by copper as reflected in a decreased rate of propagation and a lengthened lag phase. These results suggest that histidine residues in apo B play a critical role in propagating oxidative lipid damage in LDL. When LDL was incubated with diethylene-triamine-pentaacetic-acid (DTPA), a metal chelator, I found that DTPA binds copper in a redox inactive manner and prevents LDL from binding and reducing copper. In contrast, free histidine bound copper in a redox active manner but inhibited LDL oxidation by competing with LDL for copper binding.;In an extension of these studies, I also demonstrated antioxidant activity of ascorbic acid in vivo in the presence of transition metal ions. While ascorbic acid has been suggested to act as a pro-oxidant in the presence of iron by stimulation of the Fenton reaction, the results of this study, utilizing a guinea pig model system, show that ascorbic acid inhibits iron mediated damage in vivo, as measured by stable end products of lipid peroxidation, F2-isoprostane.;In total, these data support the hypothesis that ascorbic acid is an antioxidant both in vitro and in vivo, despite the presence of transition metal ions.
机译:活性氧可以介导低密度脂蛋白(LDL)的氧化:这是动脉粥样硬化发病机理中的关键步骤。相反,抗氧化剂可以通过直接清除自由基物质来防止这种氧化损伤。抗坏血酸是一种水溶性抗氧化剂和强还原剂,可直接淬灭活性氧并能抑制LDL的氧化修饰。为了研究抗坏血酸在LDL氧化和动脉粥样硬化发病中的作用,我分离了人LDL并显示抗坏血酸防止铜介导的LDL氧化。将抗坏血酸和铜与LDL一起孵育会导致形成2-氧代组氨酸,同时导致铜与LDL的结合丧失。这些结果表明了抗坏血酸通过共价修饰载脂蛋白B上过渡金属结合位点的LDL从而抑制LDL氧化的机制。改性剂。 LDL的这种修饰抑制了铜的后续氧化,这表现为传播速率降低和滞后相延长。这些结果表明,载脂蛋白B中的组氨酸残基在传播LDL中的氧化脂质损伤中起关键作用。当LDL与金属螯合剂二亚乙基三胺五乙酸(DTPA)一起孵育时,我发现DTPA以氧化还原非活性方式结合铜,并阻止LDL结合和还原铜。相反,游离的组氨酸以氧化还原活性方式结合铜,但通过与LDL竞争铜结合而抑制LDL氧化。在这些研究的扩展中,我还证明了在过渡金属离子存在下体内抗坏血酸的抗氧化活性。虽然已提出抗坏血酸通过刺激Fenton反应在铁存在下充当前氧化剂,但利用豚鼠模型系统的这项研究结果表明,抗坏血酸在体内抑制铁介导的损伤,因为总的来说,这些数据支持以下假设:尽管存在过渡金属离子,抗坏血酸在体外和体内都是抗氧化剂。

著录项

  • 作者

    Chen, Kent Y.;

  • 作者单位

    Boston University.;

  • 授予单位 Boston University.;
  • 学科 Chemistry Biochemistry.;Health Sciences Pathology.;Health Sciences Medicine and Surgery.;Biology Animal Physiology.
  • 学位 Ph.D.
  • 年度 1999
  • 页码 184 p.
  • 总页数 184
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号